[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370536-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370536-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","investigating-the-anticancer-properties-of-bacterial-toxoid-in-combination-vaccines","Investigating the Anticancer Properties of Bacterial Toxoid in Combination Vaccines","","Study investigates anticancer potential of bacterial toxoids derived from combination vaccines, framed as a Bacterial-Based Cancer Therapy approach. The work uses in vitro, immunity-independent experiments across cancer cell lines SKG and HCAM and a normal Rat Embryonic Fibroblast (REF) line. DTP vaccine-derived toxoid is tested at six concentrations and cytotoxicity is quantified by Crystal Violet assay to compute IC50. Apoptotic and cytopathological effects are assessed under an inverted microscope, with significant toxicity seen in cancer cells.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/investigating-the-anticancer-properties-of-bacterial-toxoid-in-combination-vaccines/370536/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/investigating-the-anticancer-properties-of-bacterial-toxoid-in-combination-vaccines/370536.png","ImageObject",300,407,{"name":42,"@type":43},"Sophia Brooks","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-11","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the primary aim of the study?","Question",{"text":63,"@type":64},"To investigate the anticancer properties of vaccine-derived bacterial toxoids using in vitro, immunity-independent experiments on multiple cancer cell lines.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which cell lines were tested?",{"text":68,"@type":64},"Two cancer cell lines, SKG and HCAM, and a normal Rat Embryonic Fibroblast (REF) cell line were tested.",{"name":70,"@type":61,"acceptedAnswer":71},"How was cytotoxicity measured and IC50 calculated?",{"text":72,"@type":64},"Cytotoxic effects were evaluated using the Crystal Violet assay to determine the percentage of cell death for each toxoid concentration, enabling IC50 calculation.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370536,1791055212,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},962084925636,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","RESEARCH ARTICLE  \nEditorial Process: Submission:09/12/2024 Acceptance:01/18/2025  \nInvestigating the Anticancer Properties of Bacterial Toxoid in Combination Vaccines  \nAlyaa Jabbar Qasim, Alyaa Kareem Abood, Ahmed MajeedAl-Shammari* Abstract  \nBackground: The use of bacterial vaccines as a potential Bacterial-Based Cancer Therapy (BBCT) presents an innovative approach, transforming these vaccines into multifunctional tools capable of serving dual roles in medicine. Materials and methods: This study aimed to conduct in vitro, immunity-independent experiments to investigate the anticancer properties of vaccine-derived bacterial toxoids on various cancer cell lines. Six concentrations of the DTP vaccine (5 x 10-4, 25 x 10-5, 125 x 10-6, 625 x 10-7, 312 x 10-7, and 15 x 10-6 µg/ml) were tested on two cancer cell lines (SKG and HCAM) and a normal Rat Embryonic Fibroblast (REF) cell line. The cytotoxic effects were evaluated using the Crystal Violet assay to determine the percentage of cell death for each toxoid concentration, leading to the calculation of IC50 values. Apoptotic effects and other cytopathological changes were observed under an inverted microscope. Results: The findings revealed significant toxic effects of the bacterial toxoid on the SKG and HCAM cancer cell lines (p \u003C 0.001). In contrast, the toxic effects on the normal REF cell line were evident only at the highest toxoid concentrations. Microscopic analysis showed marked cytological changes in cancer cells treated with the toxoid, with minimal impact on normal cells.  \nKeywords: Bacterial toxoid-SKG-REF-HCAM cell line-Bacterial vaccines  \nAsian Pac J Cancer Prev, 26 (1), 233-238  \nIntroduction  \nCancer is a global health problem responsible for one in six deaths worldwide and is also the main cause of death of approximately 10 million people each year [1] . Surgery, radiation therapy, and chemotherapy as single treatment or in combination are the most known options for cancer treatment for many decades as conventional treatment approaches in addition to the significant advances including stem cell therapy, targeted therapy, nanoparticles, natural antioxidants [2]. Each treatment has drawbacks, either requiring additional treatment or lacking target specificity, resulting in additional side effects on the patient. For example, chemotherapy and radiation therapy have low specificity toward cancer cells, destroying healthy and diseased cells with detrimental side effects [3] . The limitations of current cancer treatments call for alternative interventions, as cancer cells continue to evolve and build resistance against existing chemotherapeutic agents [4] . Thus, there is a dire need for new molecules with higher selectivity and specificity against cancer cells. One of the promising novel therapeutic candidates against cancer is microbial-based cancer therapy. Microorganisms, particularly bacteria, possess a broad range of proteins and peptides with antitumoral properties, such as toxins, immunotoxins, enzymes, and others [5].Toxins produced  \nby pathogenic bacteria interfere with the physiological functions of cells and are sometimes lethal. They acton the cell membrane or on some intracellular target. Occasionally, they are the sole cause of the disease; in most cases, they act in concert with other virulence factors which allow bacteria to establish themselves in the host and resist or escape its defensive mechanism [5] . Detoxification is the process by which bacterial toxins can be transformed by several and different procedures into toxoids which are not only nonpathogenic bacterial agents, but also very vital tools for extremely important medical use, including vaccination [6] . Vaccines can be highly effective tools in combating antimicrobial resistance as they reduce infections caused by antibiotic-resistant bacteria and the consumption of antibiotics associated with disease. The protection effect of bacterial vaccines depends on the immune response of th","cbCaitplRO4hdVfu","https://ap.wps.com/l/cbCaitplRO4hdVfu","pdf",711540,"English","# Abstract\n# Introduction\n# Materials and Methods\n## Cell Lines","[{\"question\":\"What is the primary aim of the study?\",\"answer\":\"To investigate the anticancer properties of vaccine-derived bacterial toxoids using in vitro, immunity-independent experiments on multiple cancer cell lines.\"},{\"question\":\"Which cell lines were tested?\",\"answer\":\"Two cancer cell lines, SKG and HCAM, and a normal Rat Embryonic Fibroblast (REF) cell line were tested.\"},{\"question\":\"How was cytotoxicity measured and IC50 calculated?\",\"answer\":\"Cytotoxic effects were evaluated using the Crystal Violet assay to determine the percentage of cell death for each toxoid concentration, enabling IC50 calculation.\"}]","Investigating the Anticancer Properties of Bacterial Toxoid in Combination Vaccines | PDF",1790189028,15,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6b6451f410f78b31ec99643147442fa9.webp",983,1390,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/30775990d958f28954ec3c9322a3a279.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/862318e0f61df98dbec0768da67f4f88.webp",981,1387,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dd64c13484b999e35a173c7a0408d721.webp",980,1385]